Functional valvular incompetence in decompensated heart failure: Noninvasive monitoring and response to medical management

American Journal of the Medical Sciences

Volumn 329, Issue 5, 2005, Pages 217-221

  Campos, Paulo Cesar ^a   D'Cruz, Ivan A ^a   Johnson, Lillie S ^a   Malhotra, Amit ^a   Ramanathan, Kodangudi B ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bioimpedance cardiography; Decompensated heart failure; Echocardiography; Functional valvular incompetence

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FUROSEMIDE; NEUROHORMONE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT ATRIUM; HEART OUTPUT; HUMAN; IMPEDANCE; ISCHEMIC HEART DISEASE; KIDNEY PERFUSION; LUNG ARTERY PRESSURE; LUNG FLUID; MALE; MITRAL VALVE REGURGITATION; MONITORING; SYMPTOMATOLOGY; SYSTEMIC CIRCULATION; SYSTEMIC VASCULAR RESISTANCE; SYSTOLE; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION;

EID: 18844386766     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200505000-00001     Document Type: Article

References (35)

1. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern Med 1990;150:769-73.
2. Vinson JM, Rich MW, Sperry JC, et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-5.
3. Schiff GD, Fung S, Speroff T, et al. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med 2003;114:625-30.
4. Felker GM, Adams KF Jr, Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 2003;145(2 Suppl):S18-25.
5. Silver MA, Pisano C. High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs. Congest Heart Fail 2003; 9:127-32.
6. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345:1689-97.
7. Weber KT, Burlew BS, Davis RC, et al. CHF: circulatory homeostasis gone awry. Congest Heart Fail 2002;8:37-48.
8. Robbins JB, Maniar PB, Cotts W, et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003;91:360-2.
9. Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-29.
10. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-43.
11. Blondheim DS, Jacobs LE, Kotler MN, et al. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991;122(3 Pt 1):763-71.
12. Weber KT, Janicki JS, Campbell C, et al. Pathophysiology of acute and chronic cardiac failure. Am J Cardiol 1987; 60:3C-9C.
13. Lapu-Bula R, Robert A, Van Craeynest D, et al. Contribution of exercise-induced mitral regurgitation to exercise stroke volume and exercise capacity in patients with left ventricular systolic dysfunction. Circulation 2002;106:1342-8.
14. Keren G, Katz S, Gage J, et al. Effect of isometric exercise on cardiac performance and mitral regurgitation in patients with severe congestive heart failure. Am Heart J 1989;118(5 Pt 1):973-9.
15. Keren G, Bier A, Strom JA, et al. Dynamics of mitral regurgitation during nitroglycerin therapy: a Doppler echocardiographic study. Am Heart J 1986;112:517-25.
16. Yoran C, Yellin EL, Becker RM, et al. Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 1979;43:773-7.
17. Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:654-8.
18. Hamilton MA, Stevenson LW, Child JS, et al. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol 1991;67:259-63.
19. Weiland DS, Konstam MA, Salem DN, et al. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:1046-50.
20. Rosario LB, Stevenson LW, Solomon SD, et al. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol 1998;32:1819-24.
21. Silver MA, Cianci P, Brennan S, et al. Evaluation of impedance cardiography as an alternative to pulmonary artery catheterization in critically ill patients. Congest Heart Fail 2004;10(Suppl 2):17-21.
22. De Maria AN, Raisinghani A. Comparative overview of cardiac output measurement methods: has impedance cardiography come of age? Congest Heart Fail 2000;6:60-73.
23. Belardinelli R, Ciampani N, Costantini C, et al. Comparison of impedance cardiography with thermodilution and direct Fick methods for noninvasive measurement of stroke volume and cardiac output during incremental exercise in patients with ischemic cardiomyopathy. Am J Cardiol 1996; 77:1293-301.
24. Greenberg BH, Hermann DD, Pranulis MF, et al. Reproducibility of impedance cardiography hemodynamic measures in clinically stable heart failure patients. Congest Heart Fail 2000;6:74-80.
25. Peacock WI, Albert NM, Kies P, et al. Bioimpedance monitoring: better than chest x-ray for predicting abnormal pulmonary fluid? Congest Heart Fail 2000;6:86-9.
26. D'Cruz IA. Echocardiographic anatomy: understanding normal and abnormal echocardiograms. Stamford, CT: Appleton & Lange; 1996.
27. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-83.
28. Spain MG, Smith MD, Grayburn PA, et al. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 1989;13:585-90.
29. Evangelista-Masip A, Bruguera-Cortada J, Serrat-Serradell R, et al. Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:373-6.
30. Keren G, Katz S, Strom J, et al. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 1989;80:306-13.
31. Keren G, Laniado S, Sonnenblick EH, et al. Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a Doppler echocardiographic study. Am Heart J 1989;118:748-54.
32. D'Cruz IA, Shroff SG, Janicki JS, et al. Differences in the shape of the normal, cardiomyopathic, and volume overloaded human left ventricle. J Am Soc Echocardiogr 1989;2: 408-14.
33. Weber KT, Janicki JS. The heart as a muscle-pump system and the concept of heart failure. Am Heart J 1979;98:371-84.
34. Sageman WS, Riffenburgh RH, Spiess BD. Equivalence of bioimpedance and thermodilution in measuring cardiac index after cardiac surgery. J Cardiothorac Vase Anesth 2002;16:8-14.
35. Van De Water JM, Miller TW, Vogel BL, et al. Impedance cardiography: the next vital sign technology? Chest 2003;123: 2028-33.